Back to search
FDAFDA · Food and drugs·Recall number Z-0853-2013

NEUROPATH 5Fx100 GUIDING CATH MC Product Code: GCB51000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices

Published February 27, 2013 · Recall initiated: January 11, 2013

Summary

FDA records medical device Class II recall Z-0853-2013, published February 27, 2013 and initiated January 11, 2013. Recalling firm: Codman & Shurtleff, Inc.; Status: Terminated; Reported quantity: 5 units; Lot: All unexpired lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Sterility of device may be compromised due to lack of package integrity

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Codman & Shurtleff, Inc.
Distributor
Worldwide Distribution - USA (nationwide) and Internationally to Austria, Belgium, Canada, Chile, Costa, Rica, Czech Republic, Denmark, France, Germany, Great Britian/UK, Ireland, Italy, Lithuania, Malaysia, Netherlands, New Zealand, Norway, Poland, Portugal, Singapore, Slovakia, Spain, and Switzerland.
Lot
All unexpired lots
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was NEUROPATH 5Fx100 GUIDING CATH MC Product Code: GCB51000000 Intended for use in the coronary, peripheral, and neurovasculature for intravascular introduction of interventional/diagnostic devices recalled?

Yes. FDA published recall Z-0853-2013 on February 27, 2013. Reported hazard: Sterility of device may be compromised due to lack of package integrity

What should I do if I have this product?

Voluntary: Firm initiated · Letter